NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

Latest News

WWI descendants see armistice through prism of personal pain

Nov 16, 2018

PARIS — William Kearsey's war was long over by the time his son ever heard about it. By then, the World War I veteran had undergone 28 surgeries to knit back together the bones and flesh of his face, which was shattered in a trench in Belgium in 1917. A century after fighting in the first war of its kind ceased, Kearsey's son, Peter, stood on a rain-soaked avenue in Paris on Sunday to honor the armistice that ended the war his father and so many other soldiers endured. "It's appropriate, really, like what they went through in the trenches....

Leaders laud fallen soldiers on eve of armistice centennial

Nov 16, 2018

PARIS — Traveling from across the world to monuments honoring soldiers who fell 100 years ago, victors and vanquished alike marked those sacrifices Saturday ahead of Armistice Day and assessed alliances that have been redrawn dramatically since the dark days of World War I. The leaders of former enemies France and Germany, in an intimate gesture that underscored their countries' current roles as guarantors of peace in Europe, held their heads together at the site north of Paris where the defeated Germans and the Allies signed the agreement that ended the 1914-18 war. After Chancellor Angela Merkel briefly snuggled her...

2 Yosemite National Park visitors die in fall from overlook

Nov 16, 2018

SAN FRANCISCO — Two visitors died in a fall from a popular overlook at Yosemite National Park that allows people to walk to the cliff's edge, where there is no railing, an official said Thursday. Park rangers were trying to recover the bodies of a female visitor and a male visitor spotted by another tourist Wednesday, spokesman Scott Gediman said. Officials are still investigating when the pair fell and from what spot at Taft Point, which is 3,000 feet (900 meters) above the famed Yosemite Valley floor, he said. Railings only exist at a small portion of the overlook, which...

New Orleans museum shows art collected by namesake duke

Nov 16, 2018

NEW ORLEANS — The New Orleans Museum of Art is winding up the city's tricentennial with an exhibition of dozens of paintings collected by the man the city is named for: Philippe II, Duke of Orleans. The duke owned 772 paintings when he died in 1723. Now 30 of them are back together for the first time in centuries, thanks to loans from museums across the United States and Europe. The exhibit runs Friday through Jan. 27. The duke's grandson, known as "Philippe Egalite" (Philippe Equality) sold most of the paintings in the early 1790s to help finance the French...

China building boom uncovers buried dinosaurs, makes a star

Nov 16, 2018

YANJI, China — At the end of a street of newly built high-rises in the northern Chinese city of Yanji stands an exposed cliff face, where paleontologists scrape away 100 million-year-old rock in search of prehistoric bones. Like many fossil excavation sites in China, this one was discovered by accident. China's rapid city building has churned up a motherlode of dinosaur fossils. While bulldozers have unearthed prehistoric sites in many countries, the scale and speed of China's urbanization is unprecedented, according to the United Nations Development Program. Perhaps no one has seized the scientific opportunity more than Xu Xing, a...

Search

Welcome to The Zig Zag World. This travel blog will help you to make the most out of your travel time with interesting destination guides. Our paths will definitely cross some day as we zigzag around the world.

Contact us: sales@thezigzagworld.com